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ABSTRACT
Laboratory rats were subcutaneously vaccinated with 100 live tetrathyridia ot Mesoces-
toides corti (Cestoda) and subsequently intraperitoneally challenged with 50 tetrathyridia.
Necropsy 30 days postintection revealed that vaccinated rats harbored 97.4% fewer worms
compared to control rats. In a second experiment, passive transfer of immunity was ac-
complished by immune serum from subcutaneously vaccinated rats. Rats receiving
immune serum harbored 33.4% lighter worm burdens compared to normal serum recip-
ients.
INTRODUCTION
Research on cestode immunology has focused on the relatively few
tapeworms with mammalian tissue-invading phases in their larval
development. The great majority of research has centered on Taenia
Linnaeus and Hymenolepis Weinland, possibly due to their economic
importance and the fact that both genera are relatively easy tomain-
tain in the laboratory. Moreover, some species belonging to these
genera are pathogenic parasites of humans and domestic animals.
Therefore, a certain amount of economic impetus has accounted for
much of the immunologicalresearch regarding these tapeworms.
Protection against Mesocestoides corti infections has been ac-
complished byvaccination ofmice with excretory-secretory (ES) pro-
ducts collected from tetrathyridia incubated in vitroand by passive
transfer of serum from chronically infected mice (Kowalski and
Thorson 1972a, 1972b). Kazacos (1976) successfully immunized mice
against M. corti bysubcutaneous inoculation of live tetrathyridia 21
days prior to intraperitoneal challenge infections.
As the relative rates of M.corti tetrathyridial proliferation are con-
siderably lower in rats than mice (Specht and Voge 1965) it was of
interest to investigate the responses of rats to immunization proced-
ures and to compare those results with the previously mentioned
studies performed with mice.
MATERIALSANDMETHODS
Stock infections
Rats (Wooster-Ohio strain) were obtained from the Department of
Animal Science, University ofArkansas. Stock infections were main-
tained in young rats (6-8 weeks old). Tetrathyridia were washed in
three rinses of Kreb's ringer solution (pH7.2) prior to intraperitoneal
(IP) injection with a sterile syringe fitted with a 21-gauge needle.
Worms were harvested from 30-day infections and used insubcutane-
ous (SC) vaccination procedures and in intraperitoneal (IP)challenge
infections.
Preparation ofimmune serum
Thirty rats (6-8 weeks old) were SC vaccinated with 100 tetrathy-
ridia according to the procedures of Kazacos (1976). Serum was col-
lected and pooled 21 days subsequent to SC vaccination.
Collection of serum
Blood was collected from control and SC vaccinated rats by
cardiac puncture using a sterile syringe fitted with a 21-gauge needle.
Blood was allowed to clot in sterile glass test tubes overnight at 2°C.
Sera from each treatment group were pooled, centrifuged (2200
rpm/10 min), and frozen until used. No preservatives were added to
any serum samples.
Subcutaneous vaccination and challenge infections
Fifteen rats (6-8 weeks old) were SC vaccinated with 100 tetrathy-
ridia as previously described. Twenty-one days later 15 SC vac-
cinated rats and 15 control rats were IP infected with 50 tetrathyridia
using a sterile syringe fitted with a 21-gauge needle. Rats were
necropsied 30 days post-infection following the procedures of
Kowalski and Thorson (1972a). Worms were fixed in 10% formalin
prior to making direct wormcounts ofeach rat's worm burden.
Passive transfer of serum and challenge infections
Thirty rats (6-8 weeks old) were IP infected with 50 tetrathyridia as
previously described. Within 2 hours each rat received an IP injec-
tion of either 2.0 ml of pooled immune serum or pooled normal
serum. Thirty days postinfection rats were necropsied and direct
worm counts were made as before.
Statistical analysis
Student's t-test was employed to determine the statistical signifi-
cance between the worm burdens from treatment and control
groups. Aprobability value of 0.05 or less was considered significant-
lydifferent.
RESULTS
Subcutaneously vaccinated rats were highlyresistant to IP chal-
lenge infections, demonstrating a 97.4% average reduction in worm
burdens compared to control rats (Table 1). Moreover, 46.7% of the
SC vaccinated rats demonstrated a "sterile immunity" (i.e., no worms
were recovered). Livers were infected in only 26.7% of the SC vac-
cinated rats.
Passive transfer of immunity using pooled serum from SC vac-
cinated rats resulted in a 33.4% average reduction in worm burdens
compared to rats receiving normal serum (Table 1). Liver necropsies
revealed exceptionally light worm burdens inall 15 rats receiving
immune serum.
DISCUSSION
Subcutaneous vaccination of rats with live tetrathyridia produced a
high degree of protection to IP challenge infections. Kazacos (1976)
observed a 43.9% average reduction in worm burdens in mice SC
vaccinated and IP challenged with tetrathyridia of Mesocestoides
corti. As the rate of tetrathyridial proliferation is considerably slower
in rats than mice, it might be assumed that the "immuno-physiolog-
ical" mechanisms of rats have a greater retarding effect on tetrathyri-
dial proliferation than those mechanisms inmice. The results of the
present study suggest that prior SC vaccination augmented this pro-
cess which resulted in significantly lower wormburdens and in some
cases, a "sterile immunity". Itshould be noted that in SC vaccinated
rats tetrathyridia were actually eradicated rather than just suppressed
from asexually reproducing. Incontrast, Kazacos' (1976) study of SC
vaccinated mice revealed that tetrathyridia continued to asexually
proliferate, although at decreased rates.
As would be expected, passive transfer of pooled immune serum
was less effective inprotection than SC vaccination. Pooled immune
serum recipients demonstrated a 33.4% average decrease in worm
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burdens compared to rats receiving normal serum. In contract,
Kowalski and Thorson (1972a) demonstrated a 78% average reduc-
tion inM. corti worm burdens following passive transfer of immune
serum. Itshould be noted that they utilized serum from chronically
infected mice and the challenge infection period was 10 days while a
30-day infection period was used inthe present study.
The extremely low rate of tetrathyridial proliferation in rats neces-
sitated a 30-day challenge infection period in the present study. A
greater reduction inworm burdens following serum treatment might
have been observed if rats were necropsied 10 days postinfection.
However, preliminary studies of rats harboring 10-day infections
indicated great disparities of wormburdens within treatment groups.
The fact that SC vaccination elicited a greater degree of protection
than immune serum suggests that other immunological factors might
augment humoral immune mechanisms against M.corti infections in
rats.
The complexities of cestode immunology remain to be completely
elucidated. The unique biological characteristics of the Mesoces-
toides corti tetrathyridium make it an ideal model for such investiga-
tions.
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Table 1. Effects of subcutaneous vaccination and passive transfer of serum on intraperitoneal challenge infections with tetrathyridia of
Mesocestoides cortiinrats.
No. of tetrathyridia recovered
30 days pos t infect ion
Percent
No. No. of tetra- reduction
of thyridia in Mean Total compared to
rats Treatment IP challenge (standard error) (range) controls
15 subcutaneous 50 2.8* (±0.88) 42 (0-20) 97.4
vaccinat ion
15 untreated 50 115.7 (±2.47) 1,646 (97-128)
cont rols
15 2.0 ml 50 74.7* (±3.08) 1,120 (49-90) 33.4
immune
serum
15 2.0 ml 50 112.2 (±3.51) 1,683 (91-131)
normal
serum
* Significantly different from controls, P<0.05
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